EBERBACH, GERMANY

Our Eberbach, Germany facility is our biggest softgel development and manufacturing facility in Europe with capacity of 12.8 billion softgel capsules per year. It features integrated softgel manufacturing services including coating and packaging simplify supply chain management and deliver products faster to market. The facility can handle highly potent and cytotoxic compound with our self-contained, separated cytotoxic suite. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges.

Size: 370,580 ft²

Documents:

• Eberbach PO Terms (German)
• Eberbach PO Terms (English)
• Eberbach Richtlinie fuer Fremdfirmen
• Eberbach Sicherheitshinweise fuer Fremdfirmen
• Eberbach Merkblatt für Arbeiten von Fremdhandwerkern
• Catalent Standard Commercial Terms and Conditions
• Catalent Allgemeine Geschäftsbedingungen

CAPABILITIES:

• Analytical services
• Integrated softgel manufacturing services with coating and packaging capabilities
• Formulation development and manufacturing services for:
  • Controlled Substances
  • Cytotoxics
  • Highly Potent Compounds
  • Hormones 
• Manufacturing services for Investigational medical products in bulk
• Rx and OTC softgel development and manufacturing

FEATURED TECHNOLOGIES

• OptiForm® Solution Suite
• RP Scherer Softgel Technology
• Vegicaps® Technology

ACCREDITATIONS

• ANVISA Approved
• FDA Approved
• MHLW (Japan) Approved
• EMA Approved

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.